Thrombosis, Venous Clinical Trial
Official title:
Comparative Analysis of Injectable Anticoagulants for Thromboprophylaxis Post Cancer-related Surgery
Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism
(PE), is a common post-operative complication. The effectiveness of fondaparinux compared
with other injectable anticoagulants in VTE following major orthopedic and abdominal surgery
has been evaluated in database studies; however, the effectiveness of injectable
anticoagulant medications following cancer-related surgeries in the practice setting has not
been as well documented.
The objective of this study is to analyze patient records from a national hospital database
and compare the outcomes and costs between four types of injectable anticoagulant
medications that were prescribed for the prevention of VTE following cancer-related surgery.
This analysis will assess and quantify the outcomes, resource utilization, and cost of care
for patients receiving fondaparinux, enoxaparin, dalteparin or unfractionated heparin. The
outcomes of interest include the occurence of VTE, rates of major bleeds, medical resource
utilization, and total costs (medical plus pharmacy).
The source of data for this study is the Premier Perspective Database™. This hospital claims
database links de-identified inpatient medical, pharmacy, and billing data from more than
500 hospitals.
This study is a retrospective cohort study that uses propensity score matching to adjust for
the differences between the numbers of patients treated with each medication.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04503135 -
Catheter Associated Asymptomatic Thrombosis in Intensive Care Unit
|
||
| Completed |
NCT01691495 -
ARIXTRA® Adherence in SVT Patients.
|
N/A | |
| Not yet recruiting |
NCT06149533 -
Evaluate the Efficacy and Safety of Edoxaban on Prevention of Catheter-related Thrombosis (CRT) in Cancer Patients
|
Phase 3 | |
| Active, not recruiting |
NCT05396157 -
Venous Thromboembolism in Hematologic Malignancy and Hematopoietic Cell Transplant Patients: a Retrospective Study
|
||
| Completed |
NCT00312013 -
Effects Of Nadroparin In Patients With Lung, Pancreas Or Prostate Cancer
|
Phase 3 | |
| Not yet recruiting |
NCT06288906 -
Acute and Subacute Iliofemoral and/or Caval Deep Vein Thrombosis: Evaluation of Mechanical Thrombectomy Systems
|
||
| Completed |
NCT00443053 -
Evaluation Of Fondaparinux (Also Called ARIXTRA) 2.5 mg Subcutaneously Once Daily For The Treatment Of Superficial Thrombophlebitis (Also Known As Superficial Vein Thrombosis)
|
Phase 3 | |
| Completed |
NCT00911157 -
The Treatment of Acute Deep Vein Thrombosis (DVT) of GSK576428 (Fondaparinux Sodium) in Japanese Patients
|
Phase 3 | |
| Completed |
NCT00320398 -
Total Hip Replacement Study Of GSK576428 (Fondaparinux Sodium)
|
Phase 3 | |
| Completed |
NCT01064362 -
Hemorrhage Risk Prescribed Arixtra
|
N/A | |
| Recruiting |
NCT05710705 -
Bioimpedance Measurement of Abdominal Free Flaps During Arterial and Venous Weaning in Breast Reconstruction
|
N/A | |
| Completed |
NCT00843492 -
A Study to Evaluate the Efficacy and Safety of Fondaparinux for the Prevention of Venous Blood Clots in Patients With a Plaster Cast or Other Type of Immobilization for a Below-knee Injury Not Needing Surgery
|
Phase 3 | |
| Not yet recruiting |
NCT06349291 -
Venous Thrombosis After Removal of Central Venous Catheter
|
||
| Recruiting |
NCT06094387 -
The Use of Thrombin Generation Assay in Detection of Central Line Related Thrombosis (CRT) in Critically Ill Patients
|